1029088-56-9

Basic information

• Product Name: tert-butyl 5-(4-p-tolylthiazol-2-ylcarbamoyl)thiazol-2-ylcarbamate
• Synonyms: tert-butyl 5-(4-p-tolylthiazol-2-ylcarbamoyl)thiazol-2-ylcarbamate
• CAS NO: 1029088-56-9
• Molecular Weight: 416.525
• Mol File: 1029088-56-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl 5-(4-p-tolylthiazol-2-ylcarbamoyl)thiazol-2-ylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 5-(4-p-tolylthiazol-2-ylcarbamoyl)thiazol-2-ylcarbamate(1029088-56-9)
• EPA Substance Registry System: tert-butyl 5-(4-p-tolylthiazol-2-ylcarbamoyl)thiazol-2-ylcarbamate(1029088-56-9)

Safety Data

• Hazardous Substances Data: 1029088-56-9(Hazardous Substances Data)

Upstream product

• 2103-91-5 2-amino-4-(p-methylphenyl)-1,3-thiazole 
• 302964-02-9 2-[(tert-butoxycarbonyl)amino]-1,3-thiazole-5-carboxylic acid 

Downstream Products

• 1029088-58-1 2-amino-N-(4-p-tolylthiazol-2-yl)thiazole-5-carboxamide 

Relevant articles and documents

NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS

The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.